Form 4: CareDx Director Michael Goldberg Receives Quarterly Stock Grant

Michael Goldberg, a director at CareDx, Inc., acquired 3,686 shares of common stock on April 4, 2024, as part of the company's Outside Director Compensation Policy.

Summary

• Michael Goldberg, a director at CareDx, Inc., filed a Form 4 on April 8, 2024, reporting a transaction that occurred on April 4, 2024.
• The transaction involved the acquisition of 3,686 shares of CareDx common stock.
• These shares were granted automatically as part of the Issuer's Outside Director Compensation Policy, in lieu of cash compensation for non-employee directors.
• Following the transaction, Goldberg directly owns 124,702 shares of CareDx common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally. The grant aligns director interests with shareholders, which is a positive.

Positives

• The stock grant aligns the director's interests with those of the shareholders.
• The automatic grant provides a predictable compensation structure for non-employee directors.

Industry Context

Director compensation through stock grants is a common practice in publicly traded companies to align the interests of directors with those of shareholders.

Comparison to Industry Standards

• Stock grants for non-employee directors are a typical component of compensation packages in the biotechnology and healthcare industries.
• Companies like Exact Sciences and Myriad Genetics also utilize stock grants as part of their director compensation policies.
• The size of the grant is comparable to grants provided by similar companies of CareDx's market capitalization.

Stakeholder Impact

• The stock grant aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.

Key Dates